- Report
- March 2025
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- March 2025
- 185 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- April 2025
- 130 Pages
Global
From €3910EUR$4,365USD£3,333GBP
€4344EUR$4,850USD£3,703GBP
- Report
- April 2025
- 130 Pages
Global
From €3910EUR$4,365USD£3,333GBP
€4344EUR$4,850USD£3,703GBP
- Report
- March 2024
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- November 2022
- 63 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- March 2022
- 300 Pages
Global
From €3583EUR$4,000USD£3,054GBP
- Report
- May 2024
- 131 Pages
Global
From €5821EUR$6,499USD£4,962GBP
- Report
- May 2024
- 131 Pages
Global
From €5821EUR$6,499USD£4,962GBP
- Report
- July 2022
- 131 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- May 2023
- 160 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- March 2023
- 147 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- July 2022
- 100 Pages
Global
From €2463EUR$2,750USD£2,100GBP
- Report
- January 2022
- 60 Pages
Global
From €3538EUR$3,950USD£3,016GBP
- Report
- January 2022
- 200 Pages
Global
From €6718EUR$7,500USD£5,726GBP
- Report
- June 2024
- 200 Pages
Global
From €7121EUR$7,950USD£6,070GBP
- Report
- June 2024
- 260 Pages
Global
From €7121EUR$7,950USD£6,070GBP
- Report
- November 2023
- 171 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- January 2022
- 120 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- February 2024
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP

Diabetic Neuropathy is a type of nerve damage caused by diabetes. It is a common complication of diabetes, affecting up to 70% of people with the condition. Symptoms of diabetic neuropathy can include pain, numbness, tingling, and loss of sensation in the feet, legs, and hands. It can also cause problems with balance and coordination, as well as digestive issues. Endocrinologists are medical professionals who specialize in the diagnosis and treatment of endocrine disorders, including diabetes. They are well-equipped to diagnose and treat diabetic neuropathy, as well as provide lifestyle advice to help manage the condition.
Companies in the Diabetic Neuropathy market include Novartis, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more